Arbutus Biopharma Corp (ABUS)

SBC to Revenue

160.26%

Quarterly · Period ending:

ABUS logo

ABUS SBC to Revenue

Latest reported160.26%
ABUS Quarterly SBC/Revenue (0.00% → 160.26%)
High-resolution chart · PNG

ABUS sbc to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Arbutus Biopharma Corp SBC to Revenue — Quarterly
Period endingSBC to Revenue
160.2564%
0.7587%
120.0761%
238.7524%
8.0454%
202.0408%
103.6849%
161.3144%
184.241%
131.4621%
80.3263%
53.3061%
63.7282%
31.8678%
26.6934%
28.8138%
14.4934%
13.7986%
44.6351%
48.3533%
74.839%
77.3781%
59.9749%
110.8339%
105.4822%
96.9148%
-1.4215%
49.5263%
579.4793%
224.1532%
47.4374%
115.1859%
213.9068%
66.5042%
60.4578%
57.7336%
491.1453%
1,916.1702%
-2,400.5128%
575.4522%
7,155.6634%
1,312.1061%
58.0167%
184.5756%
159.5%
62.6655%
13.0805%
10.2017%
59.6908%
26.8172%
5.8444%
7.4218%
3.9618%
6.1267%
13.474%
4.6148%
4.1417%
5.0126%
6.5275%
4.5655%
1.9156%
2.0347%
2.1551%
1.0764%
2.0847%
14.5915%
0.8426%
1.5332%
2.4942%
3.8478%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.